Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials Heerajnarain Bulluck, Alex Sirker, Yoon K. Loke, David Garcia-Dorado, Derek J. Hausenloy International Journal of Cardiology Volume 202, Pages 228-237 (January 2016) DOI: 10.1016/j.ijcard.2015.09.005 Copyright © 2015 Terms and Conditions
Fig. 1 PRISMA 2009 flow diagram. International Journal of Cardiology 2016 202, 228-237DOI: (10.1016/j.ijcard.2015.09.005) Copyright © 2015 Terms and Conditions
Fig. 2 Forest plot for all-cause mortality, adenosine v control. International Journal of Cardiology 2016 202, 228-237DOI: (10.1016/j.ijcard.2015.09.005) Copyright © 2015 Terms and Conditions
Fig. 3 Forest plot for non-fatal MI, adenosine v control. International Journal of Cardiology 2016 202, 228-237DOI: (10.1016/j.ijcard.2015.09.005) Copyright © 2015 Terms and Conditions
Fig. 4 Forest plot for heart failure, adenosine v control. International Journal of Cardiology 2016 202, 228-237DOI: (10.1016/j.ijcard.2015.09.005) Copyright © 2015 Terms and Conditions
Fig. 5 Forest plot for myocardial blush grade 0 or 1, adenosine v control. International Journal of Cardiology 2016 202, 228-237DOI: (10.1016/j.ijcard.2015.09.005) Copyright © 2015 Terms and Conditions
Fig. 6 Forest plot for TIMI flow <3, adenosine v control. International Journal of Cardiology 2016 202, 228-237DOI: (10.1016/j.ijcard.2015.09.005) Copyright © 2015 Terms and Conditions